SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 32.13-0.5%Nov 28 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: aknahow who wrote (16625)2/16/2004 2:07:44 PM
From: Robert K.   of 17367
 
I would like to remind both of you that bpi-21 was never denied. >>>>IT WAS NEVER SUBMITTED.
AND
Being a baxter property, it is very likely that xoma had ANY
say in the submission matter. But NOW its another story.

>I would instead put the ONUS on the fda and submit the product with the data AS IS. Let the FDA have the hot potato of trying to deny bpi-21 for dying children.
(right now the fda can just claim it was never submitted)

>and the company knows of my request for them to just submit as is. (can you imagine the shock if they did)
>the company has said they will take whatever path they believe will bring them to an approval. We will see and I am looking for a STRONG bpi backer or another probe. skd
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News